• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There are few data on how exposure to ADHD for a long time could affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to adhd medication names medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that more high-quality studies are required.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the advantages of using them against the risks to the fetus. Physicians don't have the information needed to make unequivocal recommendations but they can provide information regarding risks and benefits that aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not face a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers used a vast population-based case-control study to determine the prevalence of major structural birth defects in infants born to mothers who took stimulants during the early stages of pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts examined the cases to confirm that the classification was accurate and to minimize any bias.

However, the study had its limitations. Researchers were unable in the beginning to differentiate the effects triggered by the medication from the disorder. This limitation makes it difficult to know whether the small associations observed in the groups that were exposed are due to medication use or the confounding effect of comorbidities. In addition, the researchers did not study long-term offspring outcomes.

The study showed that babies whose mothers had taken adhd inattentive type medication medication during pregnancy were at a slightly higher chance of being admitted to the neonatal care unit (NICU) as compared to mothers who did not take any medication during pregnancy, or had stopped taking their medication before or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication that was used during pregnancy.

Women who used stimulant ADHD medication during pregnancy were also at an elevated risk of having a caesarean section or having a child with a low Apgar score (less than 7). These increases appear to be unrelated to the type of medication taken during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during early pregnancy could be offset by the greater benefits to both mother and child of continued treatment for the woman's disorder. Physicians should discuss the issue with their patients and, if possible, assist them in developing strategies to improve their coping abilities that may minimize the effects of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and treated with medication, the issue of whether to continue or stop treatment during pregnancy is one that more and more doctors confront. These decisions are often taken without clear and authoritative evidence. Instead, doctors must take into account their own experience, the experience of other doctors and the research that has been conducted on the subject.

The issue of risk to the infant can be particularly tricky. The research on this issue is based on observations rather than controlled studies and the results are conflicting. In addition, most studies limit their analysis to live births, which can underestimate the severity of teratogenic effects that could cause abortion or termination of the pregnancy. The study discussed in the journal club addresses these limitations, by examining both data on live and deceased births.

The conclusion The conclusion: While certain studies have demonstrated an association between ADHD medications used for Adhd and the possibility of certain birth defects, other studies have not found any evidence of a link and the majority of studies have a neutral or slightly negative impact. As a result an accurate risk-benefit analysis is required in every instance.

For women suffering from ADHD, the decision to stop taking medication is difficult if not impossible. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of being isolated. A decrease in medication for inattentive adhd could affect the ability to drive safely and perform work-related tasks, which are vital aspects of everyday life for those with ADHD.

She suggests that women who are unsure whether to continue taking the medication or stop it due to their pregnancy should educate family members, colleagues, and friends about the condition, the effects on daily functioning, and the benefits of continuing the current treatment plan. It will also help a woman feel supported in her decision. It is important to remember that certain medications can be absorbed through the placenta so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the medication could be passed on to the baby.

Risk of Birth Defects

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about what impact the drugs could have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this topic. With two massive data sets, researchers were able to analyze more than 4.3 million pregnancies to determine whether stimulant medication use increased the risk of birth defects. Researchers discovered that, while the overall risk is low, the first trimester ADHD medication exposure was associated with slightly higher rates of certain heart defects, like ventriculoseptal defect.

The authors of the study found no connection between early medication use and other congenital abnormalities, like facial clefting, or club foot. The results are in line with previous studies that showed a small, but significant increase in the number of cardiac malformations among women who began taking ADHD medication prior to the time of the time of pregnancy. This risk increased during the latter part of pregnancy when many women began to stop taking their medication.

Women who used ADHD medication in the first trimester of their pregnancies were also more likely to have a caesarean section, a low Apgar score after delivery and a baby who required breathing assistance during birth. However the researchers of the study were not able to eliminate bias due to selection by restricting the study to women who didn't have any other medical issues that could have contributed to these findings.

Researchers hope that their study will help doctors when they meet pregnant women. They suggest that although the discussion of the benefits and risks is important but the decision to stop or continue treatment must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also caution that, while stopping the medication is an option, it is not an option to consider due to the high prevalence of depression and other mental health problems for women who are expecting or post-partum. Additionally, research suggests that women who stop taking their medication will have a tough adjustment to life without them after the baby is born.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women with ADHD who must work through their symptoms while attending physician appointments, getting ready for the arrival of their child and adapting to new routines in the home are often faced with a number of difficulties. Therefore, many women choose to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant drugs are absorbed by breast milk in low quantities, so the risk for breastfeeding infant is minimal. The rate of medication exposure can vary depending upon the dosage and frequency of administration as well as the time of day. In addition, different medications are introduced into the baby's system through the gastrointestinal tract or through breast milk. The effect on the health of a newborn isn't fully known.

Because of the lack of evidence, some doctors might be tempted to stop taking stimulant drugs during the course of pregnancy. This is a difficult choice for the patient, who must weigh the benefits of keeping her medication for odd and adhd against the potential dangers to the foetus. Until more information is available, doctors should ask all pregnant patients about their history of ADHD and whether they plan or are taking to take medication during the perinatal time.

Numerous studies have proven that women can continue to take their ADHD medication without risk during pregnancy and while breast-feeding. In response, maternity.s333.xrea.com a growing number of patients are choosing to do so. They have found after consulting with their doctor that the benefits of continuing their current medication outweigh any potential risks.

Women who suffer from ADHD who plan to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be provided to help women with ADHD recognize their symptoms and underlying disorder, learn about available treatment options and reinforce existing coping strategies. This should be a multidisciplinary approach with best over the counter adhd medication for adults GP doctors, obstetricians and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and child, and monitoring for Most Common Adhd Medication Uk indicators of deterioration, and, if needed modifications to the medication regimen.